First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [18F]FB(ePEG12)12-Exendin-4: A Phase 1 Clinical Study Targeting GLP-1 Receptor Expression Cells in Pancreas

Distinctive detection of insulinoma using [18F]FB(ePEG12)12-exendin-4 PET/CT

(2021) Takaaki Murakami et al.   Scientific Reports

Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond

(2021) Takaaki Murakami et al.   Frontiers in Endocrinology

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects

(2020) Takaaki Murakami et al.   Journal of Diabetes Investigation

Noninvasive longitudinal quantification of β-cell mass with [111In]-labeled exendin-4

(2019) Naotaka Fujita et al.   FASEB JOURNAL

PET-based dosimetry of [68Ga]Ga-NODAGA-exendin-4 in humans, a tracer for beta cell imaging.

(2019) Marti Boss et al.   JOURNAL OF NUCLEAR MEDICINE

Investigation of the preservation effect of canagliflozin on pancreatic beta cell mass using SPECT/CT imaging with 111In-labeled exendin-4

(2019) Keita Hamamatsu et al.   Scientific Reports

Evaluation of 18 F-labeled exendin(9-39) derivatives targeting glucagon-like peptide-1 receptor for pancreatic β-cell imaging

(2018) Hiroyuki Kimura et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Establishment of a method for in-vivo SPECT/CT imaging analysis of 111 In-labeled exendin-4 pancreatic uptake in mice without the need for nephrectomy or a secondary probe

(2018) Keita Hamamatsu et al.   NUCLEAR MEDICINE AND BIOLOGY

In vivoandex vivo19-fluorine magnetic resonance imaging and spectroscopy of beta-cells and pancreatic islets using GLUT-2 specific contrast agents

(2016) Sayuan Liang et al.   Contrast Media & Molecular Imaging

Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes: Table 1

(2016)   DIABETES CARE

Glucagon-like Peptide 1 Receptor Signaling in Acinar Cells Causes Growth-Dependent Release of Pancreatic Enzymes

(2016) Nicolai J. Wewer Albrechtsen et al.   Cell Reports

Synthesis and evaluation of 18F-labeled mitiglinide derivatives as positron emission tomography tracers for β-cell imaging

(2014) Hiroyuki Kimura et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Inside the pancreas: progress and challenges of human beta cell mass quantification

(2014) Markus Tiedge   DIABETOLOGIA

Non-invasive quantification of the beta cell mass by SPECT with 111In-labelled exendin

(2014) Maarten Brom et al.   DIABETOLOGIA

Detection of Metastatic Insulinoma by Positron Emission Tomography With [68Ga]Exendin-4—A Case Report

(2014) Olof Eriksson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study

(2013) Emanuel Christ et al.   Lancet Diabetes & Endocrinology

In Vivo Imaging of Endogenous Pancreatic  -Cell Mass in Healthy and Type 1 Diabetic Subjects Using 18F-Fluoropropyl-Dihydrotetrabenazine and PET

(2012) M. D. Normandin et al.   JOURNAL OF NUCLEAR MEDICINE

Glucagon-Like Peptide-1 Receptor Imaging for Localization of Insulinomas

(2009) Emanuel Christ et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM